46 min listen
Bypassing Surgery: An Oral Pill for the Treatment of Morbid Obesity—Hasan Celiker—Xeno Biosciences
Bypassing Surgery: An Oral Pill for the Treatment of Morbid Obesity—Hasan Celiker—Xeno Biosciences
ratings:
Length:
31 minutes
Released:
Nov 15, 2018
Format:
Podcast episode
Description
Gastric bypass surgery is the most effective form of treatment for morbid obesity and a familiar term to most of us, but until recently, the underlying mechanism that makes it so successful has been largely misunderstood. Most people—including health professionals—attribute the weight loss that follows from this surgery to reduced stomach size and therefore reduced food intake and malabsorption, but the evidence is pointing elsewhere: to the changes in gut microbiota that occur after the surgery. Hasan Celiker is the founder and chief executive officer of Xeno Biosciences, a company that’s using what they’ve learned about the effectiveness of gastric bypass surgery to develop an alternative and significantly less invasive form of treatment for obesity: an oral pill that mimics the changes in gut microbiota that occur after the surgery, allowing for weight loss and a significant reduction in conditions associated with obesity, such as diabetes and fatty liver disease. Celiker delves into the details of digestive mechanisms, the differences between aerobic and anaerobic bacteria and the role of each in the microbiome, how and where in the body Xeno Bioscience’s pill takes effect, and the metabolic changes brought about by both the pill and the surgery. Hit play and visit xenobiosciences.com to learn more.
Released:
Nov 15, 2018
Format:
Podcast episode
Titles in the series (100)
Interview With Eddy Travia, Chief Executive Officer/Co-Founder of Coinsilium: Eddy Travia is the CEO and Co-Founder of Coinsilium, a company which is a ‘first mover’ in connecting the public through the public capital markets, with the Blockchain network technology ecosystem… by Finding Genius Podcast